Imagene AI, a Tel Aviv, Israel-based precision oncology diagnosis company, raised $21.5m in funding.
The funding included:
- $3m in seed funding led by Blumberg Capital, and
- $18.5m in Series A round led by Larry Ellison, Dr. David Agus, and Eyal Gura.
Founded in 2020 by Dean Bitan, Jonathan Zalach, and Shahar Porat, Imagine AI develops AI diagnostic technology that uses a digitized biopsy image to deliver real-time molecular analysis, setting a new standard by increasing the level of accuracy and reducing the time required for results to minutes.
The company collaborates with top-tier medical centers and pharmaceutical companies worldwide, making therapeutic decisions for cancer more accurate and accessible, profiling patients for clinical trials, and accelerating the drug development process.
The mentioned products are currently used for research purpose only and subject to regulatory clearances in the applicable markets.
FinSMEs
03/05/2022